Novartis Pharmaceuticals UK Ltd
Over
Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of more than 140 nationalities work at Novartis around the world.
Adres
Novartis Pharmaceuticals UK Limited
2nd Floor, The WestWorks Building, White City Place
195 Wood Lane, London, W12 7FQ
United Kingdom
Contact details
Medische Informatietelefoon
44-1276-698370
Openingstijden
Mon-Fri 9am-5pm GMT (excl. bank holidays)
Medische informatie E-mail
medinfo.uk@novartis.com
Bijwerkingen en productklachten
If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the information leaflet that comes in the pack.
You can report side effects via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ (UK). By reporting side effects, you can help provide more information on the safety of your medication.
Adverse events can also be reported to Novartis patient safety online through the patient safety information (PSI) tool at https://psi.novartis.com.
Meld een ongewenst voorval Telefoon
44-1276-698370
Meld een ongewenst e-mailbericht
medinfo.uk@novartis.com
Company website
https://www.novartis.co.uk
Facebook
https://www.facebook.com/NovartisUK/
LinkedIn
https://www.linkedin.com/company/novartis-uk-limited/
Twitter
https://twitter.com/novartisuk
Novartis producten
Geneesmiddelen gemarkeerd met een ▼ zijn onderworpen aan aanvullende monitoring. Dit maakt een snelle identificatie van nieuwe veiligheidsinformatie mogelijk. U kunt helpen door bijwerkingen te melden die u kunt krijgen.
Afinitor®
(everolimus)
Aimovig® ▼
(erenumab)
Alomide®
(lodoxamide, trometamol)
Atectura Breezhaler®
(indacaterol, mometasone)
Azarga®
(brinzolamide, timolol )
Azopt®
(brinzolamide)
Beovu® ▼
(Brolucizumab)
Betoptic®
(betaxolol)
Certican®
(everolimus)
Ciloxan®
(ciprofloxacin)
Co-Diovan®
(valsartan, hydrochlorothiazide)
Cosentyx®
(secukinumab)
Desferal®
(desferrioxamine)
Diovan®
(valsartan)
DuoTrav®
(travoprost, timolol )
Enerzair Breezhaler®
(glycopyrronium, indacaterol, mometasone)
Entresto®
(sacubitril, valsartan)
Estradot®
(estradiol)
Eucreas®
(vildagliptin, metformin )
Exelon®
(rivastigmine)
Exforge®
(amlodipine, valsartan)
Exjade® ▼
(deferasirox)
Extavia®
(recombinant interferon beta-1b)
Fabhalta ▼
(iptacopan hydrochloride monohydrate)
Famvir®
(famciclovir)
Femara®
(letrozole)
Finlee®
(dabrafenib)
Galvus®
(vildagliptin)
Gilenya® ▼
(fingolimod)
Glivec® ▼
(imatinib)
Ilaris®
(canakinumab)
Jakavi®
(ruxolitinib)
Kesimpta® ▼
(ofatumumab)
Kisqali® ▼
(ribociclib)
Kymriah® ▼
(tisagenlecleucel)
Lamisil®
(terbinafine )
Leqvio® ▼
(inclisiran)
Lioresal®
(baclofen)
Lucentis®
(ranibizumab)
Luxturna® ▼
(Voretigene neparvovec)
Maxidex®
(dexamethasone)
Maxitrol®
(dexamethasone, polymyxin B, neomycin )
Mayzent® ▼
(Siponimod)
Mekinist®
(trametinib)
Moxivig®
(moxifloxacin)
Myfortic®
(mycophenolic acid as mycophenolate sodium)
Neoral®
(ciclosporin)
Nevanac®
(nepafenac)
Onbrez®
(indacaterol)
Opatanol®
(olopatadine)
Piqray® ▼
(alpelisib)
Prometax®
(rivastigmine)
Revolade®
(Eltrombopag)
Riamet®
(artemether, lumefantrine)
Rydapt® ▼
(midostaurin)
Sandimmun®
(ciclosporin)
Sandostatin®
(octreotide)
Sebivo®
(telbivudine)
Seebri®
(glycopyrronium)
Signifor®
(pasireotide)
Simbrinza®
(brinzolamide, brimonidine)
Simulect®
(basiliximab)
Spexotras®
(trametinib )
Tafinlar®
(dabrafenib)
Tasigna®
(nilotinib)
Tegretol®
(carbamazepine)
Tobradex®
(tobramycin, dexamethasone )
Transiderm-Nitro®
(nitroglycerin)
Travatan®
(travoprost)
Trileptal®
(oxcarbazepine)
Tyverb®
(lapatinib)
Ultibro®
(indacaterol, glycopyrronium )
Voltarol®
(diclofenac)
Votrient®
(pazopanib)
Votubia®
(everolimus)
Xolair®
(omalizumab)
Zofran®
(ondansetron)
Zykadia® ▼
(ceritinib)
